Review Article

Prognostic and Clinicopathological Significance of MUC Family Members in Colorectal Cancer: A Systematic Review and Meta-Analysis

Table 3

Results of meta-regression analysis exploring the source of heterogeneity with OS and DFS/RFS.

Mucins phenotypeCovariatesUnivariate analysis (OS)Univariate analysis (DFS)
CoefficientSE valueCoefficientSE value

MUC1Antibody0.0550.0870.538-0.1420.8820.883
Cut-off value0.02970.0320.3690.1550.2950.635
TNM stage0.3650.3240.2810.7731.1060.535
Country0.0480.4620.3230.1550.2950.635
Year-0.0010.0140.964-0.0770.1150.552

MUC2Antibody-0.2040.2150.3670.5500.2520.094
Cut-off value-0.0270.0430.552-0.0300.2210.898
TNM stage-0.3090.1240.054-0.2700.8380.763
Country0.0070.0480.8910.1800.0500.023
Year0.0360.0300.2640.1080.0300.022

MUC5ACAntibody0.4640.2690.135-0.1390.4340.769
Cut-off value0.1870.1580.282-0.2480.1930.288
TNM stage0.9230.2110.055-0.6520.9610.546
Country0.2500.2400.339-0.3790.2930.287
Year0.1350.0730.8590.1020.0690.236